"At Ascension Polly and Bill Van Dyke Cancer Center – Ascension Columbia St. Mary’s Hospital Milwaukee, Wisconsin, our doctors and nurses listen to understand your health care needs and concerns and answer your questions. Then, we deliver a care plan with personalized cancer treatments and support programs. Our medical, radiation and surgical oncologists, oncology-certified nurses, palliative care specialists, genetic counselors, dietitians, and rehabilitation therapists focus on your needs. We’re dedicated to supporting you throughout your cancer treatment."

During the past decade, Columbia St. Mary's Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia St. Mary's Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Columbia St. Mary's Cancer Center" are "Breast Cancer" (4 trials), "Anal Cancer" (1 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "Breast Tumor" (1 trials) and "Cancer of the Breast" (1 trials). Many other conditions were trialed in "Columbia St. Mary's Cancer Center" in a lesser frequency.

Most popular intervention types in "Columbia St. Mary's Cancer Center" are "Drug" (6 trials), "Other" (2 trials), "Radiation" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "BluePrint 80 gene expression profile" (1 trials), "Chlorambucil" (1 trials), "Cisplatin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia St. Mary's Cancer Center" are 4 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Columbia St. Mary's Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Columbia St. Mary's Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia St. Mary's Cancer Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".